However, as for EBNA1 T cell responses, comprehensive analysis of LMP1-specific adaptive responses in MS cohorts is needed to determine the relevance of this cross-reactivity for disease pathogenesis. This evidence concerns the gene PDLIM7 and myeloid sarcoma.